CN102380023A - Chinese medicament for treating benign prostatic hyperplasia - Google Patents
Chinese medicament for treating benign prostatic hyperplasia Download PDFInfo
- Publication number
- CN102380023A CN102380023A CN2011102155624A CN201110215562A CN102380023A CN 102380023 A CN102380023 A CN 102380023A CN 2011102155624 A CN2011102155624 A CN 2011102155624A CN 201110215562 A CN201110215562 A CN 201110215562A CN 102380023 A CN102380023 A CN 102380023A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- prostatic hyperplasia
- chinese
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a Chinese medicament for treating benign prostatic hyperplasia, and belongs to the field of Chinese medicaments for treating renal and urogenital disorders. The Chinese medicament and has good effect and quick action. The Chinese medicament is prepared from common anemarrhena, Chinese angelica, ganoderma lucidum, red-rooted salvia root, pseudo-ginseng, fringed pink, jape jasmine and other raw materials, has the effects of reinforcing vital energy and consolidating constitution, invigorating vital energy and nourishing blood, activating blood circulation and removing stasis, inducing diuresis for removing edema, promoting diuresis and treating stranguria, and has the advantages of remarkable effect, definite drug effect and quick action.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of urinary system.
Background technology
The present Chinese medicine aspect that is used to treat male prostatic hyperplasia, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect; So that large quantities of prostatic hyperplasia patients are because of can not get the treatment of active drug for a long time; Frequent frequent micturition, urgent micturition, dysurea, unable, the urine retention of urine, urinary incontinence, protracted course of disease; Symptoms such as very misery, and Chang Bingfa urine retention, hematuria, perineal position pain.Patient and family members thereof are very dissatisfied.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating prostatic hyperplasia, and it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, and the slower problem that takes effect is effective, instant effect, and it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
1, a kind of Chinese medicine of treating prostatic hyperplasia adopts the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
The Rhizoma Anemarrhenae 5---18 parts of 15 parts of Radix Angelicae Sinensis 6---18 portions of Ganodermas 6---
Radix Salviae Miltiorrhizae 6---15 parts of 18 portions of Radix Notoginseng 1---3 portions of Herba Dianthis 5---
Fructus Gardeniae 5---15 parts
The Chinese medicine of this treatment prostatic hyperplasia is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves
→Hot water (95 ℃) lixiviate with 1:20
→Lixiviating solution decompression, concentrated
→95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal
→Add 75% ethanol, the deposition polysaccharide
→Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, the Rhizoma Anemarrhenae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Angelicae Sinensis the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, enhancing human body immunity power; Radix Salviae Miltiorrhizae, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; Be aided with Rhizoma Anemarrhenae clearing away heat-fire, nourshing Yin and drynsessmoistening prescription; Herba Dianthi, Fructus Gardeniae inducing diuresis for treating stranguria syndrome, Herba Dianthi clearing heat and freeing strangury removing heat from blood, the diuresis of Fructus Gardeniae heat clearing and blood cooling, the two 5 be a usefulness mutually, effect that heat clearing and blood cooling is treating stranguria enhancing is used to treat urinary obstruction, the odynuria effect is distinguished.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, the merit that eliminating dampness by diuresis is treating stranguria, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Rhizoma Anemarrhenae 500 gram Radix Angelicae Sinensis 700 kairine sesames 700 grams
Radix Salviae Miltiorrhizae 700 gram Radix Notoginseng 100 gram Herba Dianthis 500 grams
Fructus Gardeniae 500 grams
Press predetermined weight, Ganoderma is extracted with decoction and alcohol sedimentation technique; With conventional water extraction process the Rhizoma Anemarrhenae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted, process extract fine powder 360 grams altogether, Radix Notoginseng is ground into fine powder; Mix with said extracted thing fine powder; Stir, process fine particle, the capsule of packing into No. 0; Process 1533 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
2, get following prescription (weight is unit by gram):
The Rhizoma Anemarrhenae 1000 gram Radix Angelicae Sinensis 1200 kairine sesames 1200 grams
Radix Salviae Miltiorrhizae 1200 gram Radix Notoginseng 200 gram Herba Dianthis 1000 grams
Fructus Gardeniae 1000 grams
By above-mentioned same method, process 2866 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
3, get following prescription (weight is unit by gram):
The Rhizoma Anemarrhenae 1500 gram Radix Angelicae Sinensis 1800 kairine sesames 1800 grams
Radix Salviae Miltiorrhizae 1800 gram Radix Notoginseng 300 gram Herba Dianthis 1500 grams
Fructus Gardeniae 1500 grams
By above-mentioned same method, process 4300 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
4, get following prescription (by weight):
7 parts of 7 portions of Ganodermas of 6 parts of Radix Angelicae Sinensis of the Rhizoma Anemarrhenae
6 parts of 1 portion of Herba Dianthis of 7 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
6 parts of Fructus Gardeniaes
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
5, get following prescription (by weight):
16 parts of 16 portions of Ganodermas of 12 parts of Radix Angelicae Sinensis of the Rhizoma Anemarrhenae
12 parts of 2 portions of Herba Dianthis of 16 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
12 parts of Fructus Gardeniaes
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
Clinical data:
The present invention is example with the prostatic hyperplasia, through 19 routine clinical observations.Selecting the tcm diagnosis prostatic hyperplasia is standard: male's limb is soft weak, physical weakness, and it is not smooth to urinate---and frequent micturition, urgent micturition, dysurea, urine are unable, urine retention, urine are hesitated, urine retention; Clinical rectal touch can contact the prostate of increase.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, be the male all, there is not other serious disease, the age is 55 years old-81 years old, 69.3 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are obviously alleviated; Urine retention, urine are hesitated, urine retention obviously alleviates; The visible prostate of rectal touch increases (expansion of prostate both sides page or leaf) and alleviates.
2, effective: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are alleviated to some extent; Urine is hesitated, urine retention alleviates to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking the Chinese medicinal capsule that the specific embodiment of the invention 2 is made, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.3 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.19 philtrums of clinical experiment, produce effects 11 people, effective 6 people, invalid 2 people, total effective rate 89.4%.
Claims (1)
1. Chinese medicine of treating prostatic hyperplasia is characterized in that: said Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
The Rhizoma Anemarrhenae 5---18 parts of 15 parts of Radix Angelicae Sinensis 6---18 portions of Ganodermas 6---
Radix Salviae Miltiorrhizae 6---15 parts of 18 portions of Radix Notoginseng 1---3 portions of Herba Dianthis 5---
Fructus Gardeniae 5---15 parts
The Chinese medicine of this treatment prostatic hyperplasia is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves
→Hot water (95 ℃) lixiviate with 1:20
→Lixiviating solution decompression, concentrated
→95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal
→Add 75% ethanol, the deposition polysaccharide
→Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, the Rhizoma Anemarrhenae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102155624A CN102380023A (en) | 2011-07-29 | 2011-07-29 | Chinese medicament for treating benign prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102155624A CN102380023A (en) | 2011-07-29 | 2011-07-29 | Chinese medicament for treating benign prostatic hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102380023A true CN102380023A (en) | 2012-03-21 |
Family
ID=45820123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011102155624A Pending CN102380023A (en) | 2011-07-29 | 2011-07-29 | Chinese medicament for treating benign prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102380023A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102626489A (en) * | 2012-04-20 | 2012-08-08 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating prostatic hyperplasia |
| CN102670790A (en) * | 2012-06-07 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for curing prostatic hyperplasia |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972349A (en) * | 2010-09-29 | 2011-02-16 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
| CN102068529A (en) * | 2010-09-16 | 2011-05-25 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treatment of prostatic hyperplasia |
-
2011
- 2011-07-29 CN CN2011102155624A patent/CN102380023A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102068529A (en) * | 2010-09-16 | 2011-05-25 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treatment of prostatic hyperplasia |
| CN101972349A (en) * | 2010-09-29 | 2011-02-16 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102626489A (en) * | 2012-04-20 | 2012-08-08 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating prostatic hyperplasia |
| CN102670790A (en) * | 2012-06-07 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for curing prostatic hyperplasia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN102389530A (en) | Traditional Chinese medicine for curing benign prostatic hyperplasia | |
| CN102114172A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102172374A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102048831A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN102114074A (en) | Traditional Chinese medicine for treating diabetic diarrhea | |
| CN102389522A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN102327350A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN101972349A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102068529A (en) | Traditional Chinese medicine for treatment of prostatic hyperplasia | |
| CN102380023A (en) | Chinese medicament for treating benign prostatic hyperplasia | |
| CN102389498A (en) | Traditional Chinese medicine for curing diabetic diarrhea | |
| CN102389525A (en) | Traditional Chinese medicine for curing benign prostatic hyperplasia | |
| CN102389477A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102389523A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102631459A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN102389531A (en) | Traditional Chinese medicine for curing chronic prostatitis | |
| CN102302606A (en) | Chinese medicament for treating chronic prostatitis | |
| CN102379965A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN101972426A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN102380037A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN102631442A (en) | Traditional Chinese medicine (TCM) for treating prostatic hyperplasia | |
| CN102670787A (en) | Chinese medicine for treating prostatoplasia | |
| CN101961407A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN102670790A (en) | Traditional Chinese medicine for curing prostatic hyperplasia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120321 |